Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06318975 · ClinicalTrials.gov registry record · NA

Text-Based Messaging Strategies for Preventing Subsequent Problematic Alcohol Use

A NA study of Alcohol Drinking and Binge Drinking, sponsored by University of Virginia.

Recruiting
Registry status
NA
Development phase
3,000
Enrollment target
1
Study location

NCT06318975 is a NA study of Alcohol Drinking and Binge Drinking that is actively recruiting participants, run by University of Virginia. The registered enrollment target is 3,000 participants, above the 595-participant average among 85 other Alcohol Drinking trials with a reported enrollment target (404% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06318975, a NA study of Alcohol Drinking and Binge Drinking, is actively recruiting participants, sponsored by University of Virginia.

RECRUITING
Registry status
NA
Development phase
3,000 participants
Enrollment target
1
Study location

Study Summary

Binge drinking, and its health/social consequences are substantial public health concerns, with a high prevalence in young adults, especially in the US military. Alcohol consumption in the military is very high and normative, but there is zero tolerance for alcohol-related legal trouble, and Air Force Airmen who experience this (e.g., DUI, sexual assault) typically receive a disciplinary action referred to as an Alcohol Related Incident (ARI). Brief Alcohol Interventions (BAIs) for alcohol misuse are effective in young adults who report binge drinking. Many BAI studies targeted young adults who drink hazardously; these individuals are typically not interested in abstaining but may try decreasing the amount or change the manner in which they drink in order to reduce harmful consequences. The investigators previously published the results of a BAI group-based intervention that reduced ARIs in over 150,000 Airmen on average by 16%. Since 2010, the BAI has been disseminated to most USAF Airmen in Technical Training. However, it is clear additional research is needed to enhance the efficacy of the intervention and reduce risks associated with problem drinking. One strategy to improve health outcomes is well-timed, tailored, and automated text messages. Building on the researchers' preliminary study where text messages reduced driving after drinking as well as total drinks consumed before driving, text messaging may be highly effective when sent at the precise time that Airmen gain access to alcohol (the first time they are allowed off base), a standard time for all Technical Trainees. One challenge to conducting alcohol research in the military is the lack of privileged communication. As a result, it is difficult to obtain valid self-reports due to a tendency to deny or minimize use. The investigators recently developed and validated a method for collecting anonymous data over time. This will be the first study in the military, as well as the first large scale, adequat

Interventions

  • BEHAVIORAL Brief Alcohol Intervention
  • BEHAVIORAL Automated and Targeted Text Messages

Study Locations (1)

Texas

  • JBSA Lackland - San Antonio

Trial Details

FieldValue
Enrollment Target 3,000 participants
Start Date 2023-12-01
Est. Completion 2028-12-31
Phase NA

Sponsor

University of Virginia

449 total trials

What the Registry Record Tells You About NCT06318975

The ClinicalTrials.gov registry entry for NCT06318975 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 3,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 595-participant average among 85 other Alcohol Drinking trials with a reported enrollment target (404% higher). The listed sponsor is University of Virginia, which has 449 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Alcohol Drinking appearing as the primary indexed condition, and to 2 interventions - of which Brief Alcohol Intervention is the first listed.

NCT06318975 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT06318975 about?

NCT06318975 is a clinical study titled "Text-Based Messaging Strategies for Preventing Subsequent Problematic Alcohol Use". Binge drinking, and its health/social consequences are substantial public health concerns, with a high prevalence in young adults, especially in the US military. Alcohol consumption in the military is very high and normative, but there is zero tolerance for alcohol-related legal trouble, and Air For...

What is the current status of trial NCT06318975?

This trial is currently recruiting. It is a NA study. The enrollment target is 3,000 participants. The study started on 2023-12-01. Estimated completion is 2028-12-31.

What conditions does trial NCT06318975 study?

This clinical trial studies the following conditions: Alcohol Drinking, Binge Drinking, Text Messaging.

What interventions are being tested in trial NCT06318975?

The interventions under investigation include: Brief Alcohol Intervention (BEHAVIORAL), Automated and Targeted Text Messages (BEHAVIORAL).

Who is sponsoring clinical trial NCT06318975?

This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06318975 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Alcohol Drinking

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.